Factor Assay – VIII, IX, XI, XII
BRD ID: 2022
Tier: SOP
Source: TCP Project
Number of times downloaded: 1157
Description
This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical
Center (BMC) to measure clotting factor activity in plasma as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).
Biospecimens
FluidPlasma
Diagnoses
NeoplasticCarcinoma
Normal
Topics
Biospecimen Aliquots and Components
Platform-specific Methodology